Table 3. Cox Regression according to cardiovascular death or HF rehospitalization
Variables Univariate analysis Univariate analysis Univariate analysis Multivariate analysis Multivariate analysis Multivariate analysis
Hazard ratio 95% CI p-value Hazard ratio 95% CI p-value
NYHA class ≥ III 1.094 0.137 – 8.766 0.933
eGFR 0.960 0.926 – 0.995 0.027
Logalism of NT-pro BNP 2.322 0.883 – 6.111 0.088
TR≥III 2.100 0.607 – 7.262 0.241
TAPSE 0.874 0.789 – 0.968 0.01 0.788 0.788 – 0.987 0.029
Residual MR >2+ 11.652 3.257 – 41.691 < 0.001 9.373 2.581 – 34.033 0.001
*, Assessed at discharge; , included eGFR, TR III or IV, TAPSE and Residual MR >2+. CI, confidence interval; eGFR, estimated glomerular filtration rate; MR, mitral regurgitation; NT-pro BNP, N-terminal pro brain natriuretic peptide; NYHA, New York heart association; TAPSE, tricuspid annular plane systolic excursion; TR, tricuspid regurgitation. *, Assessed at discharge; , included eGFR, TR III or IV, TAPSE and Residual MR >2+. CI, confidence interval; eGFR, estimated glomerular filtration rate; MR, mitral regurgitation; NT-pro BNP, N-terminal pro brain natriuretic peptide; NYHA, New York heart association; TAPSE, tricuspid annular plane systolic excursion; TR, tricuspid regurgitation. *, Assessed at discharge; , included eGFR, TR III or IV, TAPSE and Residual MR >2+. CI, confidence interval; eGFR, estimated glomerular filtration rate; MR, mitral regurgitation; NT-pro BNP, N-terminal pro brain natriuretic peptide; NYHA, New York heart association; TAPSE, tricuspid annular plane systolic excursion; TR, tricuspid regurgitation. *, Assessed at discharge; , included eGFR, TR III or IV, TAPSE and Residual MR >2+. CI, confidence interval; eGFR, estimated glomerular filtration rate; MR, mitral regurgitation; NT-pro BNP, N-terminal pro brain natriuretic peptide; NYHA, New York heart association; TAPSE, tricuspid annular plane systolic excursion; TR, tricuspid regurgitation. *, Assessed at discharge; , included eGFR, TR III or IV, TAPSE and Residual MR >2+. CI, confidence interval; eGFR, estimated glomerular filtration rate; MR, mitral regurgitation; NT-pro BNP, N-terminal pro brain natriuretic peptide; NYHA, New York heart association; TAPSE, tricuspid annular plane systolic excursion; TR, tricuspid regurgitation. *, Assessed at discharge; , included eGFR, TR III or IV, TAPSE and Residual MR >2+. CI, confidence interval; eGFR, estimated glomerular filtration rate; MR, mitral regurgitation; NT-pro BNP, N-terminal pro brain natriuretic peptide; NYHA, New York heart association; TAPSE, tricuspid annular plane systolic excursion; TR, tricuspid regurgitation. *, Assessed at discharge; , included eGFR, TR III or IV, TAPSE and Residual MR >2+. CI, confidence interval; eGFR, estimated glomerular filtration rate; MR, mitral regurgitation; NT-pro BNP, N-terminal pro brain natriuretic peptide; NYHA, New York heart association; TAPSE, tricuspid annular plane systolic excursion; TR, tricuspid regurgitation.